-+ 0.00%
-+ 0.00%
-+ 0.00%

GSI Creos (TSE:8101) Stock Draws Attention After EPS Pushes Higher

Simply Wall St·08/11/2026 21:32:48
Listen to the news

GSI Creos walked into this earnings day with the stock quietly grinding higher over the past month, not exploding but edging up as expectations built. The market now has to reconcile that calm move with a quarter where basic earnings per share landed at ¥76.51 and net income reached ¥932 million. That jump in profit per share versus recent quarters is the real shock to the system. The key question for you is whether today’s share price reaction reflects that improving earnings power or if traders are latching onto a narrower story.

Is GSI Creos trading at a genuine discount, or is this lower P/E simply compensation for softer margins and slower recent earnings growth? Compare the stock's pricing power against detailed cash flow assumptions on our valuation analysis for GSI Creos

Q1 2027 Earnings Summary

  • Revenue (Q1 2027 vs. Q1 2026): ¥39,597 million vs. ¥37,801 million (steady year on year increase)
  • Net Income (Excl. Extra Items) (Q1 2027 vs. Q1 2026): ¥932 million vs. ¥877 million (modest year on year growth)
  • Basic EPS (Q1 2027 vs. Q1 2026): ¥76.51 per share vs. ¥71.46 per share (higher earnings per share year on year)
  • Trailing 12 Month Basic EPS (Q1 2027 vs. Q1 2026): ¥212.13 per share vs. ¥210.79 per share (largely stable earnings per share over the last year)

Prefer visual charts to scrolling through lines of raw figures? Get a full visual view of GSI Creos, including its valuation, analyst context and recent earnings in the company report for GSI Creos.

TSE:8101 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
TSE:8101 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

GSI Creos earnings and the supportive bullish signals

For a stock like GSI Creos that is often pitched as a diversified industrial and consumer platform, the latest quarter broadly fits a constructive story. Revenue of ¥39,597 million and net income of ¥932 million sit above the prior year period. Basic EPS and trailing 12 month EPS are both slightly higher. That points to a business that is at least holding its ground while spanning textiles, consumer, industrial and healthcare. The recent 30 day and 90 day share price gains suggest investors are starting to give that stability some credit.

Where the bearish worries still have a foothold

There is still material for a more cautious view on GSI Creos. Net income and EPS only show modest progress versus Q1 2026, which can feed the idea that this diversified model is steady rather than strongly compounding. Trailing 12 month EPS is almost unchanged. That can reinforce concerns about limited earnings momentum despite the broad business mix. For investors who want a clean, high growth story around semiconductors or healthcare, these numbers may look more like incremental improvement than a clear break from the past.

With margins thin at 1.4% and earnings growth recently slowing to 0.5%, it is important to verify how resilient GSI Creos really is. Check the debt, cash and dividend coverage in our financial health analysis of GSI Creos stock.

Stay Ahead With Simply Wall St

If GSI Creos has your attention after its steady earnings per share and revenue progress, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch for a more attractive entry point. Once you decide to take a position, keep your decisions focused with the Portfolio Command Center that highlights only the most important updates for your holdings. For a broader view and extra context around GSI Creos, use the Community to see how other investors are thinking about the same risks and potential catalysts. This way you can spot key shifts early, stay informed and move ahead of the wider market.

Seeking Alternatives Beyond GSI Creos

Fresh stock ideas do not sit still. Breakout stories gather momentum, quiet compounders get caught, and weak links start dropping. Scan what others miss while it matters and get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.